Literature DB >> 25432720

Pathogenic mechanisms of neurodegeneration in Parkinson disease.

Stephen Mullin1, Anthony H V Schapira2.   

Abstract

The last 2 decades represent a period of unparalleled advancement in the understanding of the pathogenesis of Parkinson disease (PD). The discovery of several forms of familial parkinsonism with mendelian inheritance has elucidated insights into the mechanisms underlying the degeneration of dopaminergic neurons of the substantia nigra that histologically characterize PD. α-Synuclein, the principal component of Lewy bodies, remains the presumed pathogen at the heart of the current model; however, concurrently, a diverse range of other mechanisms have been implicated. The creation of a coherent disease model will be crucial to the development of effective disease modifying therapies for sporadic PD.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lewy bodies; Mitochondrial dysfunction; Parkinson disease; α-Synuclein

Mesh:

Substances:

Year:  2015        PMID: 25432720     DOI: 10.1016/j.ncl.2014.09.010

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  31 in total

1.  RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.

Authors:  Fernanda M Lopes; Leonardo Lisbôa da Motta; Marco A De Bastiani; Bianca Pfaffenseller; Bianca W Aguiar; Luiz F de Souza; Geancarlo Zanatta; Daiani M Vargas; Patrícia Schönhofen; Giovana F Londero; Liana M de Medeiros; Valder N Freire; Alcir L Dafre; Mauro A A Castro; Richard B Parsons; Fabio Klamt
Journal:  Neurotox Res       Date:  2017-02-02       Impact factor: 3.911

Review 2.  Precision medicine for disease modification in Parkinson disease.

Authors:  Alberto J Espay; Patrik Brundin; Anthony E Lang
Journal:  Nat Rev Neurol       Date:  2017-01-20       Impact factor: 42.937

3.  Cilostazol Mediated Nurr1 and Autophagy Enhancement: Neuroprotective Activity in Rat Rotenone PD Model.

Authors:  Shireen A Hedya; Marwa M Safar; Ashraf K Bahgat
Journal:  Mol Neurobiol       Date:  2018-02-10       Impact factor: 5.590

Review 4.  Genetic risk factors in Parkinson's disease.

Authors:  K J Billingsley; S Bandres-Ciga; S Saez-Atienzar; A B Singleton
Journal:  Cell Tissue Res       Date:  2018-03-13       Impact factor: 5.249

Review 5.  Mitochondrial bioenergetics decay in aging: beneficial effect of melatonin.

Authors:  Giuseppe Paradies; Valeria Paradies; Francesca M Ruggiero; Giuseppe Petrosillo
Journal:  Cell Mol Life Sci       Date:  2017-08-07       Impact factor: 9.261

6.  Gallic Acid Protects 6-OHDA Induced Neurotoxicity by Attenuating Oxidative Stress in Human Dopaminergic Cell Line.

Authors:  Y Chandrasekhar; G Phani Kumar; E M Ramya; K R Anilakumar
Journal:  Neurochem Res       Date:  2018-04-18       Impact factor: 3.996

Review 7.  Chemiexcitation and Its Implications for Disease.

Authors:  Douglas E Brash; Leticia C P Goncalves; Etelvino J H Bechara
Journal:  Trends Mol Med       Date:  2018-05-08       Impact factor: 11.951

8.  FLZ Attenuates α-Synuclein-Induced Neurotoxicity by Activating Heat Shock Protein 70.

Authors:  Xiu-Qi Bao; Xiao-Liang Wang; Dan Zhang
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

9.  NADPH ameliorates MPTP-induced dopaminergic neurodegeneration through inhibiting p38MAPK activation.

Authors:  Jing-Si Zhou; Zhou Zhu; Feng Wu; Ying Zhou; Rui Sheng; Jun-Chao Wu; Zheng-Hong Qin
Journal:  Acta Pharmacol Sin       Date:  2018-05-16       Impact factor: 6.150

10.  Nonhuman Primate Models of Neurodegenerative Disorders.

Authors:  Marina E Emborg
Journal:  ILAR J       Date:  2017-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.